Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gynevac in Bacterial Vaginosis
NCT02173184Phase 3Unknown
- Sponsor
- AMVAC Chemical
- Start
- Jun 2014
- Primary completion
- Apr 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of gynevac in bacterial vaginosis (BV), sponsored by AMVAC Chemical. Status: unknown.
02
Drugs
gynevac
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT02173184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173184.